|
Study to evaluate immunogenicity and safety of one dose of GSK Bios’ measles-mumps-rubella-varicella vaccine given to healthy children previously primed with one dose of measles-mumps-rubella vaccine |
Combined Measles, Mumps, Rubella, Varicella Vaccine |
208136/019 (MeMuRu-OKA-019) |
|
Measles; Mumps; Rubella; Varicella |
Phase 3 |
|
|
|
|
An annotated case report form is not available for this study. A blank case report form will be provided. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
September 2015 |